Publications by authors named "Senxia Zhao"

Claim this Profile
P
Polo-like kinase 1 inhibitor NMS-P937 represses nasopharyngeal carcinoma progression via induction of mitotic abnormalities.
Jing Gao, Weirong Huang, Senxia Zhao, Rong Wang, Zhilin Wang

J Biochem Mol Toxicol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/mTOR inhibitor VS-5584 combined with PLK1 inhibitor exhibits synergistic anti-cancer effects on non-small cell lung cancer.
Senxia Zhao, Yibin Li, Gang Li, Juanping Ye, Rong Wang

Eur J Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway.
Nan Ding, Abin You, Senxia Zhao, Hu Yang, Chunping Lai

Med Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway.
Rong Wang, Yihan Hou, Guojun Geng, Xiaolei Zhu, Zhilin Wang, Senxia Zhao

Am J Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis